GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Enlivex Therapeutics Ltd (NAS:ENLV) » Definitions » 6-1 Month Momentum %

Enlivex Therapeutics (Enlivex Therapeutics) 6-1 Month Momentum % : 184.96% (As of May. 01, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Enlivex Therapeutics 6-1 Month Momentum %?

6-1 Month Momentum % is the total return of the stock from 6-month ago to 1-month ago. As of today (2024-05-01), Enlivex Therapeutics's 6-1 Month Momentum % is 184.96%.

The industry rank for Enlivex Therapeutics's 6-1 Month Momentum % or its related term are showing as below:

ENLV's 6-1 Month Momentum % is ranked better than
94.86% of 1518 companies
in the Biotechnology industry
Industry Median: 4.14 vs ENLV: 184.96

Competitive Comparison of Enlivex Therapeutics's 6-1 Month Momentum %

For the Biotechnology subindustry, Enlivex Therapeutics's 6-1 Month Momentum %, along with its competitors' market caps and 6-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Enlivex Therapeutics's 6-1 Month Momentum % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Enlivex Therapeutics's 6-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Enlivex Therapeutics's 6-1 Month Momentum % falls into.



Enlivex Therapeutics  (NAS:ENLV) 6-1 Month Momentum % Calculation

6-1 Month Momentum % is calculated as following:

6-1 Month Momentum %=( Price 1-month ago / Price 6-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Enlivex Therapeutics  (NAS:ENLV) 6-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 6-1 Month Momentum % measures the total return to a stock over the past six months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Enlivex Therapeutics 6-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Enlivex Therapeutics's 6-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Enlivex Therapeutics (Enlivex Therapeutics) Business Description

Traded in Other Exchanges
Address
14 Einstein Street, Nes Ziona, ISR, 7403618
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.

Enlivex Therapeutics (Enlivex Therapeutics) Headlines

From GuruFocus

Enlivex Appoints Andrew Singer to its Board of Directors

By sperokesalga sperokesalga 04-17-2023

Enlivex to Present at the 2023 Jefferies Healthcare Conference

By sperokesalga sperokesalga 06-06-2023